Blood Test to Measure DNA Damage in Blood

N/ATerminatedNCT00523471

AHS Cancer Control Alberta40 enrolled

Overview

To check the radiosensitivity level in individual patients based on their DNA damage level.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Prostate Cancer

Interventions

Blood testPROCEDURE

Eligibility

Sex: MALE

Medical Language ↔ Plain English

Inclusion Criteria: * prostate cancer diagnosis * undergoing radiotherapy * agree to participate in study Exclusion Criteria: * not willing to participate * not undergoing radiotherapy

Locations (1)

Cross Cancer Institute

Edmonton, Alberta, Canada

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.